Published : 20 Feb 2024
We are pleased to announce that Aagami has received Contract Extension and Expansion of scope from its US based client.
The client is an Award-winning New York biotech specializing in RNAi /gene therapy/cell therapy.
The client is also marching towards its next mission to lead the next healthcare revolution by uncovering the drivers of autoimmune diseases to advance therapeutics.
Client is looking for strategic partners and investors. If you would like to know more, please contact us.